Ellenrieder V - Search Results

1

TGFbeta-regulated transcriptional mechanisms in cancer.

Ellenrieder V, Buck A, Gress TM. Ellenrieder V, et al. Int J Gastrointest Cancer. 2002;31(1-3):61-9. doi: 10.1385/IJGC:31:1-3:61. Int J Gastrointest Cancer. 2002. PMID: 12622416 Review.

2

Role of extracellular matrix in pancreatic diseases.

Gress TM, Menke A, Bachem M, Müller-Pillasch F, Ellenrieder V, Weidenbach H, Wagner M, Adler G. Gress TM, et al. Among authors: ellenrieder v. Digestion. 1998 Nov-Dec;59(6):625-37. doi: 10.1159/000007567. Digestion. 1998. PMID: 9813385 Free article. Review. No abstract available.

3

Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells.

Wenger C, Ellenrieder V, Alber B, Lacher U, Menke A, Hameister H, Wilda M, Iwamura T, Beger HG, Adler G, Gress TM. Wenger C, et al. Among authors: ellenrieder v. Oncogene. 1999 Jan 28;18(4):1073-80. doi: 10.1038/sj.onc.1202395. Oncogene. 1999. PMID: 10023684

4

Invasion and metastasis in pancreatic cancer.

Ellenrieder V, Adler G, Gress TM. Ellenrieder V, et al. Ann Oncol. 1999;10 Suppl 4:46-50. Ann Oncol. 1999. PMID: 10436784 Review.

5

Use of representational difference analysis to study the effect of TGFB on the expression profile of a pancreatic cancer cell line.

Geng MM, Ellenrieder V, Wallrapp C, Müller-Pillasch F, Sommer G, Adler G, Gress TM. Geng MM, et al. Among authors: ellenrieder v. Genes Chromosomes Cancer. 1999 Sep;26(1):70-9. doi: 10.1002/(sici)1098-2264(199909)26:1<70::aid-gcc10>3.0.co;2-a. Genes Chromosomes Cancer. 1999. PMID: 10441008

6

A phase II study of weekly 24-h infusion of high-dose 5-fluorouracil in advanced pancreatic cancer.

Lutz MP, Königer M, Muche R, Ellenrieder V, Steinkamp M, Adler G, Gress TM. Lutz MP, et al. Among authors: ellenrieder v. Z Gastroenterol. 1999 Oct;37(10):993-7. Z Gastroenterol. 1999. PMID: 10549093 Clinical Trial.

7

Role of MT-MMPs and MMP-2 in pancreatic cancer progression.

Ellenrieder V, Alber B, Lacher U, Hendler SF, Menke A, Boeck W, Wagner M, Wilda M, Friess H, Büchler M, Adler G, Gress TM. Ellenrieder V, et al. Int J Cancer. 2000 Jan 1;85(1):14-20. doi: 10.1002/(sici)1097-0215(20000101)85:1<14::aid-ijc3>3.0.co;2-o. Int J Cancer. 2000. PMID: 10585576 Free article.

8

Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM. Ellenrieder V, et al. Cancer Res. 2001 May 15;61(10):4222-8. Cancer Res. 2001. PMID: 11358848

9

TGF-beta-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system.

Ellenrieder V, Hendler SF, Ruhland C, Boeck W, Adler G, Gress TM. Ellenrieder V, et al. Int J Cancer. 2001 Jul 15;93(2):204-11. doi: 10.1002/ijc.1330. Int J Cancer. 2001. PMID: 11410867 Free article.

10

Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.

Fensterer H, Giehl K, Buchholz M, Ellenrieder V, Buck A, Kestler HA, Adler G, Gierschik P, Gress TM. Fensterer H, et al. Among authors: ellenrieder v. Genes Chromosomes Cancer. 2004 Mar;39(3):224-35. doi: 10.1002/gcc.20000. Genes Chromosomes Cancer. 2004. PMID: 14732924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page